Paroxetine Timing and Side Effects
Paroxetine should generally be taken in the morning rather than at night, as it commonly causes insomnia and sleep disturbances that can worsen when taken at bedtime.
Timing of Administration
While paroxetine can technically be taken at any time of day, morning dosing is preferable for most patients based on its sleep effects. Research demonstrates that paroxetine:
- Suppresses REM sleep dose-dependently 1, 2
- Delays sleep onset when taken in the morning (paradoxically, evening doses also disrupt sleep architecture) 1, 2
- Increases nocturnal awakenings and reduces total sleep time 1
- Causes insomnia as a common side effect (13% incidence vs 6% placebo) 3
The one exception: For vasomotor symptoms (hot flashes), the FDA-approved dose of 7.5 mg is specifically recommended at bedtime 4. However, this is a much lower dose than typical antidepressant dosing (20-50 mg).
Clinical Pitfall
Some clinicians mistakenly prescribe paroxetine at night assuming all antidepressants are sedating. Unlike mirtazapine or trazodone, paroxetine is activating rather than sedating for most patients. If a patient reports worsening insomnia on nighttime dosing, switch to morning administration.
Common Side Effects
Based on FDA labeling and clinical guidelines, the most frequent adverse effects include 3, 5:
Most Common (≥5% and twice placebo rate):
- Nausea (most common reason for discontinuation)
- Somnolence (23% vs 9% placebo) - despite causing insomnia, daytime drowsiness occurs
- Dizziness (13% vs 6%)
- Insomnia (13% vs 6%)
- Sweating (11% vs 2%)
- Tremor (8% vs 2%)
- Dry mouth
- Constipation
- Decreased appetite
- Asthenia (weakness/fatigue)
Sexual Dysfunction (Particularly Notable)
Paroxetine has the highest rate of sexual dysfunction among SSRIs 5:
- Ejaculatory disturbance: 13% vs 0% placebo
- Other male genital disorders: 10% vs 0%
- Female genital disorders: 2% vs 0%
- Higher rates than fluoxetine, fluvoxamine, nefazodone, or sertraline 5
Weight Gain
Paroxetine causes more weight gain than sertraline, trazodone, or venlafaxine 5, with increased risk at higher concentrations 6.
Serious Adverse Effects to Monitor
Suicidality: SSRIs including paroxetine increase risk of nonfatal suicide attempts (OR 1.57-2.25) 5
Other rare but serious effects 5:
- Serotonin syndrome (especially with other serotonergic drugs)
- Hyponatremia (particularly in elderly)
- Hepatotoxicity (monitor liver function with high concentrations) 6
- QT prolongation
- Seizures
Age-Related Considerations
Patients ≥65 years have 2.9-fold higher drug concentrations at the same dose 7, requiring dose reduction to avoid adverse effects.
Drug Interactions
Critical interaction: Paroxetine has the highest CYP2D6 inhibition of all antidepressants 8. This means:
- Never combine with tamoxifen - reduces tamoxifen efficacy and increases breast cancer mortality risk
- Never combine with MAOIs - risk of fatal serotonin syndrome 9
- Increases levels of other 2D6 substrates (many antipsychotics, beta-blockers, opioids)
Pregnancy Considerations
- Previously classified as Category D due to cardiac malformation concerns, though recent evidence is conflicting 10, 11
- Paroxetine is NOT preferred for new episodes during pregnancy - sertraline is preferred 11
- If already on paroxetine, switching is generally discouraged 11
Dosing Strategy
Standard starting dose: 20 mg once daily in the morning
For vasomotor symptoms: 7.5 mg at bedtime 4
Therapeutic concentration range: 65-120 ng/mL predicts optimal response with fewer adverse effects 6
CYP2D6 poor metabolizers: Require only 25% of standard dose 7
CYP2D6 intermediate metabolizers: Require 50% of standard dose 7